127 related articles for article (PubMed ID: 7955545)
1. High levels of expression of neuropeptide Y mRNA in human phaeochromocytomas.
Higuchi H; Iwasa A; Yokokawa K
Clin Exp Pharmacol Physiol; 1994 May; 21(5):359-65. PubMed ID: 7955545
[TBL] [Abstract][Full Text] [Related]
2. Long lasting increase in neuropeptide Y gene expression in rat adrenal gland with reserpine treatment: positive regulation of transsynaptic activation and membrane depolarization.
Higuchi H; Iwasa A; Yoshida H; Miki N
Mol Pharmacol; 1990 Nov; 38(5):614-23. PubMed ID: 2233698
[TBL] [Abstract][Full Text] [Related]
3. Regulation of neuropeptide Y mRNA expression in cultured human pheochromocytoma cells.
Liu J; Kahri AI; Heikkilä P; Voutilainen R
Eur J Endocrinol; 1999 Oct; 141(4):431-5. PubMed ID: 10526260
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide Y (NPY) in PC12 phaeochromocytoma cultures: responses to dexamethasone and nerve growth factor.
Allen JM; Tischler AS; Lee YC; Bloom SR
Neurosci Lett; 1984 May; 46(3):291-6. PubMed ID: 6547517
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoids increase insulin-like growth factor-II mRNA accumulation in cultured human phaeochromocytoma cells.
Liu J; Kahri AI; Heikkilä P; Blum WF; Voutilainen R
J Endocrinol; 1994 Jul; 142(1):29-35. PubMed ID: 7964281
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional regulation of the neuropeptide Y gene by nerve growth factor: antagonism by glucocorticoids and potentiation by adenosine 3',5'-monophosphate and phorbol ester.
Sabol SL; Higuchi H
Mol Endocrinol; 1990 Mar; 4(3):384-92. PubMed ID: 2160601
[TBL] [Abstract][Full Text] [Related]
7. Regulation of neuropeptide Y and its mRNA by glucocorticoids in the rat adrenal gland.
Laborie C; Bernet F; Kerckaert JP; Maubert E; Lesage J; Dupouy JP
Neuroendocrinology; 1995 Dec; 62(6):601-10. PubMed ID: 8751286
[TBL] [Abstract][Full Text] [Related]
8. Age-dependent increase in neuropeptide Y gene expression in rat adrenal gland and specific brain areas.
Higuchi H; Yokokawa K; Iwasa A; Yoshida H; Miki N
J Neurochem; 1991 Dec; 57(6):1840-7. PubMed ID: 1940903
[TBL] [Abstract][Full Text] [Related]
9. Rapid decrease in neuropeptide Y gene expression in rat adrenal gland induced by the alpha 2-adrenoceptor agonist, clonidine.
Higuchi H; Iwasa A; Miki N
Br J Pharmacol; 1991 May; 103(1):1136-40. PubMed ID: 1878751
[TBL] [Abstract][Full Text] [Related]
10. Neuropeptide Y gene expression in immortalized rat hippocampal and pheochromocytoma-12 cell lines.
Rajakumar PA; Westfall TC; Devaskar SU
Regul Pept; 1998 Feb; 73(2):123-31. PubMed ID: 9533817
[TBL] [Abstract][Full Text] [Related]
11. Rat neuropeptide Y precursor gene expression. mRNA structure, tissue distribution, and regulation by glucocorticoids, cyclic AMP, and phorbol ester.
Higuchi H; Yang HY; Sabol SL
J Biol Chem; 1988 May; 263(13):6288-95. PubMed ID: 2834371
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptide Y gene expression in PC12 cells and its regulation by nerve growth factor: a model for developmental regulation.
Allen JM; Martin JB; Heinrich G
Brain Res; 1987 Dec; 427(1):39-43. PubMed ID: 3427446
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptide Y expression distinguishes malignant from benign pheochromocytoma.
Helman LJ; Cohen PS; Averbuch SD; Cooper MJ; Keiser HR; Israel MA
J Clin Oncol; 1989 Nov; 7(11):1720-5. PubMed ID: 2809684
[TBL] [Abstract][Full Text] [Related]
14. Expression of trophic amidated peptides and their receptors in benign and malignant pheochromocytomas: high expression of adrenomedullin RDC1 receptor and implication in tumoral cell survival.
Thouënnon E; Pierre A; Tanguy Y; Guillemot J; Manecka DL; Guérin M; Ouafik L; Muresan M; Klein M; Bertherat J; Lefebvre H; Plouin PF; Yon L; Anouar Y
Endocr Relat Cancer; 2010 Sep; 17(3):637-51. PubMed ID: 20483910
[TBL] [Abstract][Full Text] [Related]
15. Effects of differentiation on neuropeptide-Y receptors and responses in rat pheochromocytoma cells.
DiMaggio DA; Farah JM; Westfall TC
Endocrinology; 1994 Feb; 134(2):719-27. PubMed ID: 8299567
[TBL] [Abstract][Full Text] [Related]
16. Release of neuropeptide Y from pheochromocytomas.
Takahashi K; Mouri T; Sone M; Murakami O; Itoi K; Ohneda M; Yoshinaga K
Endocrinol Jpn; 1990 Feb; 37(1):53-60. PubMed ID: 2384052
[TBL] [Abstract][Full Text] [Related]
17. Accumulation of enkephalin, proenkephalin mRNA, and neuropeptide Y in immunologically denervated rat adrenal glands: evidence for divergent peptide regulation.
Brimijoin S; Dagerlind A; Rao R; McKinzie S; Hammond P
J Neurochem; 1995 Mar; 64(3):1281-7. PubMed ID: 7861161
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide Y and catecholamine synthesizing enzymes and their mRNAs in rat sympathetic neurons and adrenal glands: studies on expression, synthesis and axonal transport after pharmacological and experimental manipulations using hybridization techniques and radioimmunoassay.
Schalling M; Franco-Cereceda A; Hemsén A; Dagerlind A; Seroogy K; Persson H; Hökfelt T; Lundberg JM
Neuroscience; 1991; 41(2-3):753-66. PubMed ID: 1714554
[TBL] [Abstract][Full Text] [Related]
19. Decrease in prepro-neuropeptide Y gene expression in the adrenal gland and cerebral cortex of spontaneously hypertensive rats.
Higuchi H; Nakano K; Iwasa A
Neuropeptides; 1993 Dec; 25(6):343-9. PubMed ID: 8127413
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y in phaeochromocytomas and ganglioneuroblastomas.
Adrian TE; Allen JM; Terenghi G; Bacarese-Hamilton AJ; Brown MJ; Polak JM; Bloom SR
Lancet; 1983 Sep; 2(8349):540-2. PubMed ID: 6136694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
